Login
Companies $PEN
$320.62 +$0.00 (0.0%) After hours
Penumbra Inc logo

Penumbra Inc

penumbrainc.com

What Do They Do?

Sells thrombectomy devices that remove blood clots from vessels throughout the body to specialist physicians and other healthcare providers.

How Do They Make Money?

Healthcare providers and distributors buy medical devices, with sales tied to shipment or customer receipt; hospitals use and are charged for consigned coils in procedures. In China, a partner pays fixed amounts for licensed technology and regulatory support, plus royalties on some product sales.

revenue
SegmentShareRevenue
Thrombectomy
Sold outright

68%
FY2022: 60%
Embolization and Other
Sold outright

32%
FY2022: 40%

Who Are Their Customers?

Penumbra sells directly to healthcare providers in the United States, most of Europe, Canada, Australia and Singapore; in other international markets it uses distributors. Specialist physicians use the products and influence purchasing decisions in hospitals and other healthcare settings.

Do Revenues Turn Into Profits?

Yes. It kept 13 cents of every revenue dollar as net income in FY2025 and turned 12 cents into free cash flow.

Operating income, FY2025
13% of revenue
▲ +1940% vs FY2024 ($9.3M, 1%)
Net income, FY2025
13% of revenue
▲ +1168% vs FY2024 ($14M, 1%)
Free cash flow, FY2025
12% of revenue
▲ +19% vs FY2024 ($147.3M, 12%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +16%
vs $354.7M in Q3 FY2025
Net income
▼ −8%
vs $45.9M in Q3 FY2025
Thrombectomy share of revenue vs 66.7% in Q3 FY2025

Growing. Revenue grew 88% in 4 years, from $747.6M in FY2021 to $1.4B in FY2025, about 17% a year.

Exited immersive healthcare The older report describes immersive healthcare products for rehabilitation and mental well-being; the latest says Penumbra wound down the business and permanently ceased selling those products.

Revenue over time
Thrombectomy Embolization and Other
$2B$1B$0

Who Do They Compete With?

Competes with Boston Scientific, Medtronic, Stryker, Inari Medical, and Terumo

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support